Search results
Among women who used the levonorgestrel-releasing intrauterine device (LNG-IUD), the relative risk of breast cancer was 1.21 (95% CI, 1.11–1.33) compared with never-users of hormonal contraception, but the risk did not increase with duration of use.
23 wrz 2022 · A total of 2900 premenopausal women with early breast cancer (mean [SD] age at diagnosis, 43.1 [5.6] years) were included in the present analysis (Figure 1; Table 1). At diagnosis, 2088 of 2661 patients (78.5%) had partnered status, and 2498 of 2602 patients (96.0%) had children.
6 dni temu · During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use,...
7 gru 2017 · The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95% CI, 10 to 16) per 100,000 person-years, or approximately...
16 paź 2024 · Those who used levonorgestrel IUDs had a 40 percent higher chance of developing breast cancer. For women in their 30s in the United States, that would take the risk of breast cancer from about 1 ...
2 paź 2024 · The average lifetime risk is approximately 70%, with more than half of all breast cancers in these women occurring before age 50 years. 1 Understanding whether and how use of hormonal contraception (HC) might affect these risks is important for informed decision making.
21 mar 2023 · In a large nested case–control study, which included almost 10,000 UK women aged <50 years with breast cancer, those prescribed oral combined contraceptives (containing oestrogen+progestagen), oral progestagen-only contraceptives, injectable progestagens, and progestagen-releasing IUD contraceptives were found to be at increased risk of ...
